YOLFTbeta
Oxford BioMedica PLC

Oxford BioMedica PLC

OXB · LSE · Healthcare / Biotechnology

530.00GBX-5.00 (-0.93%)

Price History

Full chart

Market Stats

Previous Close535.00
Open535.00
Day Range514.00 – 535.00
52-Week Range420.00 – 962.00
Volume183.60K
Market Cap658.50M
P/E (TTM)0.00
Forward P/E2000.00
EPS-0.32
Dividend Yield0.00%
Beta1.11
50-Day Avg499.05
200-Day Avg620.81

About

Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its LentiVector platform technology is a lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems; InAAVate, a proprietary "plug and play' dual-plasmid system for transient transfection, as well as a standard triple transfection system for AAV-based gene therapies. The company collaborates with pharmaceutical and biotechnology companies providing viral vector development and manufacturing services in lentivirus, adeno-associated virus, adenoviral vectors, and other viral vector types. The company was formerly known as Pinco 838 Limited and changed its name to Oxford Biomedica plc in October 1996. Oxford Biomedica plc was incorporated in 1996 and is headquartered in Oxford, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Frank Mathias
  • Employees1.02K
  • HeadquartersWindrush Court, Oxford, United Kingdom, OX4 6LT, UK
  • Websitehttps://www.oxb.com

Leadership

  • Dr. Frank MathiasCEO & Director · b. 1962
  • Dr. Lucinda Clair Crabtree Ph.D.CFO & Director · b. 1979
  • Mr. Eric SchmidhäuserChief Operating Officer
  • Ms. Sophia BolhassanHead of Investor Relations
  • Ms. Natalie Louise WalterChief Legal Officer & Company Secretary · b. 1973
  • Ms. Lisa DomanChief People Officer
  • Dr. Kyriacos Mitrophanous Ph.D.Chief Innovation Officer
  • Ms. Kati HudsonHead of Intellectual Property & Contracts
  • Mr. David M. Backer M.B.A.Durham Site Head
  • Dr. Sebastien RibaultChief Business Officer

Financials

Income Statement

Currency: GBP1996-09-301996-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--50.00K436.00K732.00K373.00K173.00K374.00K502.00K824.00K760.00K7.22M18.39M19.12M11.15M7.72M7.76M5.38M13.62M15.91M27.78M37.59M66.78M64.06M87.73M142.80M139.99M89.54M128.80M168.74M
Growth (%)---+772.00%+67.89%-49.04%-53.62%+116.18%+34.22%+64.14%-7.77%+849.87%+154.80%+3.95%-41.67%-30.80%+0.49%-30.70%+153.36%+16.82%+74.59%+35.33%+77.65%-4.07%+36.95%+62.77%-1.97%-36.04%+43.84%+31.01%
Cost of Revenue-----------449.00K1.29M437.00K-593.00K555.00K667.00K1.14M4.42M5.84M11.84M18.44M22.76M35.72M41.66M60.16M70.81M49.81M75.78M102.76M
Gross Profit--50.00K436.00K732.00K373.00K173.00K374.00K502.00K824.00K760.00K6.77M17.10M18.68M11.75M7.16M7.09M4.24M9.20M10.07M15.94M19.15M44.02M28.34M46.07M82.64M69.18M39.73M53.02M65.98M
Gross Margin--100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%93.78%92.96%97.71%105.32%92.81%91.40%78.79%67.57%63.30%57.39%50.94%65.91%44.24%52.52%57.87%49.42%44.37%41.17%39.10%
Operating Expense---3.89M4.84M-5.20M-10.65M-13.84M-12.28M-12.00M-10.41M-20.34M-13.06M3.43M12.95M-265.00K16.31M17.58M17.06M19.82M24.15M27.25M24.82M36.01M40.92M51.77M61.87M99.40M223.90M92.40M95.59M
Operating Income-88.00K88.00K3.94M-4.41M5.94M11.03M14.02M12.65M12.51M11.23M21.10M19.83M13.67M5.73M12.01M-9.15M-10.49M-12.82M-10.61M-14.08M-11.31M-5.67M8.00M-12.58M-5.69M20.77M-30.22M-184.17M-39.38M-29.61M
Operating Margin--7888.00%-1010.32%810.93%2956.30%8102.31%3382.89%2491.24%1363.23%2776.58%274.66%74.32%29.97%107.69%-118.57%-135.21%-238.57%-77.93%-88.52%-40.73%-15.08%11.98%-19.64%-6.49%14.54%-21.59%-205.69%-30.57%-17.55%
EBITDA-88.00K88.00K-3.63M-4.06M-5.56M-10.14M-12.66M-11.51M-9.51M-9.59M-18.82M-17.40M-11.73M-4.78M-11.46M-13.51M-9.38M-11.70M-9.46M-13.46M-11.71M2.03M12.29M-9.60M3.92M33.22M-10.80M-148.62M-14.33M-9.12M
EBITDA Margin---7258.00%-931.42%-759.70%-2717.69%-7320.23%-3076.47%-1893.63%-1163.83%-2476.58%-240.99%-63.75%-25.02%-102.73%-175.02%-120.91%-217.60%-69.50%-84.63%-42.17%5.40%18.40%-14.99%4.47%23.27%-7.71%-165.98%-11.13%-5.41%
Net Income-85.00K-85.00K-3.68M-4.19M-5.00M-8.39M-11.66M-10.74M-10.46M-9.09M-17.63M-15.29M-10.04M-3.52M-10.29M-12.63M-8.73M-11.10M-8.66M-13.02M-16.64M-9.02M7.54M-16.07M-6.25M19.01M-39.16M-157.49M-43.19M-30.13M
Net Income Margin---7362.00%-960.78%-683.33%-2249.06%-6739.88%-2871.12%-2084.46%-1102.55%-2319.21%-211.79%-54.59%-18.38%-92.26%-163.66%-112.56%-206.44%-63.60%-81.83%-59.91%-23.99%11.29%-25.08%-7.12%13.31%-27.97%-175.89%-33.53%-17.85%
R&D--2.98M3.76M5.03M8.57M10.83M10.77M9.01M9.33M19.52M22.14M22.48M14.90M15.93M14.71M14.02M13.75M16.99M20.27M24.30M21.61M29.71M22.55M29.75M40.19M60.94M59.35M4.54M62.76M
R&D as % of Total Revenue--5964.00%863.30%687.57%2297.59%6261.85%2880.48%1795.42%1131.92%2568.82%306.72%122.22%77.92%142.84%190.59%180.70%255.81%124.73%127.44%87.48%57.49%44.50%35.20%33.91%28.14%43.53%66.29%3.53%37.20%
Interest Expense173.00K173.00K262.00K216.00K531.00K1.48M818.00K711.00K13.00K31.00K29.00K30.00K24.00K33.00K15.00K8.00K3.00K4.00K238.00K1.89M4.92M9.42M6.23M5.56M912.00K888.00K8.75M11.20M9.84M13.86M
Interest Expense % of Total Revenue--524.00%49.54%72.54%397.86%472.83%190.11%2.59%3.76%3.82%0.42%0.13%0.17%0.13%0.10%0.04%0.07%1.75%11.91%17.73%25.07%9.33%8.67%1.04%0.62%6.25%12.51%7.64%8.21%

Balance Sheet

Currency: GBP1996-09-301996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.25M1.25M3.20M5.24M4.60M14.32M39.26M26.79M36.71M28.58M49.24M35.54M61.16M43.12M43.95M25.64M26.09M24.42M13.64M33.80M51.85M56.94M65.40M112.40M122.93M183.93M237.23M460.18M252.34M231.64M325.72M
Total Liabilities126.00K126.00K441.00K480.00K801.00K1.34M1.76M1.26M1.50M2.21M2.64M5.45M29.23M19.85M22.97M14.04M8.32M4.78M4.75M10.77M40.96M44.33M59.26M77.66M47.30M71.18M49.89M223.99M174.51M171.16M234.37M
Total Equity1.13M1.13M2.76M4.76M3.80M12.98M37.51M25.53M35.21M26.38M46.60M30.09M31.93M23.27M20.98M11.61M17.77M19.64M8.90M23.04M10.89M12.62M6.15M34.74M75.63M112.75M187.34M204.65M74.01M57.05M91.35M
Cash708.00K708.00K1.51M3.57M3.04M11.63M32.65M20.96M136.00K4.92M20.32M8.04M10.96M8.14M6.80M6.65M6.83M8.96M2.17M14.20M9.36M15.34M14.33M32.24M16.24M46.74M108.94M141.28M103.72M60.65M96.88M
Total Debt-------------------1.00M27.25M34.39M36.86M41.15M8.39M13.85M9.34M114.28M111.46M108.76M148.13M
Net Debt-708.00K-708.00K-1.51M-3.57M-3.04M-11.63M-32.65M-20.96M-136.00K-4.92M-20.32M-8.04M-10.96M-8.14M-6.80M-6.65M-6.83M-8.96M-2.17M-13.20M17.90M19.05M22.54M8.91M-7.85M-32.90M-99.60M-27.00M7.74M48.11M51.24M

Cash Flow

Currency: GBP1996-09-301998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-24.00K-3.37M-3.58M-4.90M-8.73M-10.30M-9.58M-10.37M-8.34M-17.13M4.73M-18.13M2.31M-12.83M-12.98M-10.04M-11.02M-6.03M-13.12M-5.11M2.98M12.87M-3.51M3.12M25.45M-12.62M-28.52M-50.63M-5.45M
Investing Cash Flow-552.00K-267.00K-162.00K-11.78M-24.49M10.39M-11.09M6.32M-5.30M4.22M-2.15M14.68M-4.04M12.69M-5.40M1.90M4.23M-5.52M-16.68M-6.41M-1.93M-10.10M-19.40M-10.80M-9.46M-56.46M2.81M5.63M-8.10M
Financing Cash Flow733.00K5.69M3.22M14.18M32.92M79.00K20.52M281.00K29.04M629.00K345.00K611.00K396.00K-6.00K18.57M10.26M23.58M23.58M24.96M17.50M-2.05M15.14M6.91M38.19M46.21M98.62M-12.70M2.91M50.59M
Capital Expenditure2.00K267.00K136.00K683.00K3.18M1.35M51.00K545.00K341.00K172.00K421.00K928.00K288.00K557.00K3.65M671.00K937.00K5.58M16.72M6.46M1.97M10.15M25.77M13.36M9.46M16.30M9.83M7.50M4.76M
Free Cash Flow-26.00K-3.64M-3.72M-5.58M-11.91M-11.64M-9.63M-10.91M-8.68M-17.30M4.31M-19.06M2.03M-13.38M-16.63M-10.71M-11.96M-11.61M-29.83M-11.56M1.01M2.72M-29.28M-10.24M15.99M-28.91M-38.35M-58.12M-10.21M
Dividends Paid-----------------1.50M-----------
FCF to OCF108.33%107.92%103.80%113.94%136.46%113.10%100.53%105.26%104.09%101.00%91.10%105.12%87.55%104.34%128.11%106.69%108.50%192.46%227.43%226.48%33.90%21.14%834.72%-328.69%62.83%229.18%134.48%114.81%187.33%
Dividend Paid to FCF------------------12.92%-----------

Earnings

Report DateApr 10, 2014Sep 1, 2014Apr 28, 2016Sep 13, 2016Mar 16, 2017Aug 17, 2017Mar 15, 2018May 30, 2018Sep 13, 2018Nov 28, 2018Mar 14, 2019May 29, 2019Sep 4, 2019Nov 27, 2019May 6, 2020Sep 17, 2020Dec 2, 2020Apr 15, 2021Sep 22, 2021Dec 1, 2021Apr 20, 2022Sep 15, 2022Nov 30, 2022Mar 1, 2023Apr 25, 2023Sep 20, 2023Nov 29, 2023Feb 28, 2024Apr 29, 2024Apr 25, 2025Sep 23, 2025Mar 26, 2026Sep 22, 2026Mar 25, 2027
EPS Estimate0.000.00-14.50-18.50-14.50-11.75-19.500.0031.820.00-2.480.004.710.00-4.22-1.220.00-4.606.650.007.80-11.900.00-25.84-25.84-30.110.00-39.15-39.15-0.08-0.31-0.05--
EPS Actual0.000.00-0.13-0.18-0.13-0.05-0.090.000.080.000.040.00-0.150.00-0.08-0.090.000.010.210.000.01-0.270.000.00-0.140.000.000.000.00-0.11-0.250.00--
Surprise--99.10%99.03%99.10%99.57%99.54%--99.75%-101.61%--103.18%-98.10%92.62%-100.22%-96.84%--99.87%97.73%-100.00%99.46%100.00%-100.00%100.00%-40.31%17.64%100.00%--
Timing---------------------After-hours--After-hoursPre-market----After-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap658.50M
Enterprise Value665.60M
Trailing P/E0.00
Forward P/E2000.00
PEG Ratio0.00
Price / Sales3.76
Price / Book10.02
EPS-0.32
Book Value0.48
Revenue (TTM)175.36M
Gross Profit (TTM)63.46M
EBITDA-22.72M
Profit Margin-23.23%
Operating Margin-26.85%
Return on Equity-89.69%
Return on Assets-7.03%
Shares Outstanding121.05M
Shares Float60.76M
Beta1.11
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • May 30, 20181:50